Trial Profile
An Exploratory, Multi-centre, Double-blind, Placebocontrolled Crossover Study, to Investigate the Bronchodilatory Efficacy of a Single Dose of Indacaterol in Fixed Combination With Mometasone Furoate Delivered Via a MDDPI (Twisthaler) in Adult Patients With Persistent Asthma Using Open Label Seretide Accuhaler (50/250 Mcg b.i.d.) as an Active Control
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Indacaterol/mometasone (Primary) ; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Novartis
- 03 Jul 2012 Additional locations (France, Germany) added as reported by European Clinical Trials Database.
- 09 Jun 2008 Actual completion date (Apr 2008) added as reported by ClinicalTrials.gov.
- 09 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.